miR-223靶向NLRP3负向调控人牙髓成纤维细胞LPS诱导的炎症反应
该研究探讨miR-223通过靶向NLRP3调控人牙髓成纤维细胞(HDPFs)中NLRP3/CASP1炎症小体通路介导的IL-1β和IL-18产生。研究发现,与健康牙髓组织相比,可逆性牙髓炎向不可逆性牙髓炎转化过程中miR-223降低而NLRP3升高(P < 0.05);荧光素酶报告实验证实NLRP3是miR-223的直接靶点。miR-223模拟物显著抑制ATP加LPS诱导的NLRP3/CASP1炎症小体通路激活(P < 0.05),而miR-223抑制剂则促进该激活(P < 0.05),提示miR-223作为负调控因子参与控制炎症因子产生。
要点
- miR-223在不可逆性牙髓炎中表达降低,NLRP3表达升高。
- NLRP3是miR-223的直接靶点。
- miR-223模拟物抑制NLRP3/CASP1炎症小体通路激活。
核心结论
- miR-223通过靶向NLRP3负向调控NLRP3/CASP1炎症小体通路介导的促炎细胞因子产生和分泌。
- 该数据揭示miRNA对NLRP3炎症小体的潜在调控作用,为未来牙髓治疗提供新的潜在治疗途径。
研究设计与样本
- 研究获取阻生第三磨牙的人牙髓组织和人牙髓成纤维细胞(HDPFs)。
- 使用miR-223模拟物和抑制剂或NLRP3质粒分别上调或下调HDPFs中miR-223或NLRP3。
- 通过TargetScan 5.1计算预测和荧光素酶报告实验确认靶点关联。
- 用qRT-PCR和Western blotting检测NLRP3、caspase-1、IL-1β和IL-18的mRNA和蛋白表达,ELISA分析IL-1β和IL-18释放。
- 采用单因素方差分析比较实验组与对照组差异,P < 0.05表示统计学显著。
主要发现
- 与健康牙髓组织相比,可逆性牙髓炎向不可逆性牙髓炎转化过程中人牙髓组织中miR-223降低而NLRP3升高(P < 0.05)。
- 计算预测和荧光素酶报告实验确认NLRP3是HDPFs中miR-223的直接靶点。
- 与ATP加LPS诱导组相比,miR-223抑制剂进一步促进ATP加LPS诱导的NLRP3/CASP1炎症小体通路激活(P < 0.05)。
- 与ATP加LPS诱导组相比,miR-223模拟物显著抑制ATP加LPS诱导的NLRP3/CASP1炎症小体通路激活(P < 0.05)。
临床怎么用
- miR-223可能作为负调控因子用于控制牙髓炎症中NLRP3/CASP1炎症小体介导的促炎细胞因子产生。
- 该发现为未来牙髓治疗提供了潜在的治疗靶点方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To investigate the effect of miR-223 on NLRP3, subsequently regulating the production of the NLRP3/CASP1 inflammasome pathway-mediated proinflammatory cytokines IL-1β and IL-18 in human dental pulp fibroblasts (HDPFs). METHODOLOGY: Human dental pulp tissue (HDPT) and HDPFs were obtained from impacted third molars. The miR-223 mimics and inhibitor or NLRP3 plasmid were used to upregulate or downregulate miR-223 or NLRP3 in HDPFs, respectively. Computational prediction via TargetScan 5.1 and a luciferase reporter assay was conducted to confirm target association. The mRNA and protein expression of NLRP3, caspase-1, IL-1β and IL-18 was determined by qRT-PCR and Western blotting, respectively. The release of IL-1β and IL-18 was analysed by ELISA. The significance of the differences between the experimental and the control groups was determined using one-way analysis of variance; P < 0.05 indicated statistical significance. RESULTS: A decrease in miR-223 and an increase in NLRP3 in HDPT occurred during the transformation of reversible pulpitis into irreversible pulpitis compared to that in healthy pulp tissue (P < 0.05). The computational prediction and luciferase reporter assay confirmed that NLRP3 was a direct target of miR-223 in HDPFs. The miR-223 inhibitor further promoted ATP plus LPS-induced NLRP3/CASP1 inflammasome pathway activation compared to the ATP plus LPS-induced group (P < 0.05). In contrast, the miR-223 mimic significantly inhibited the NLRP3/CASP1 inflammasome pathway activation induced by ATP plus LPS compared to the ATP plus LPS-induced group (P < 0.05). CONCLUSION: MiR-223 served as a negative regulator involved in the control of the production and secretion of proinflammatory cytokines mediated by the NLRP3/CASP1 inflammasome pathway by targeting NLRP3. These data provide insight into the potential regulatory effects of miRNAs on the NLRP3 inflammasome, thus opening up novel potential therapeutic avenues for future endodontic treatment.
引用
- Wang D, Sun S, Xue Y, et al. MicroRNA-223 negatively regulates LPS-induced inflammatory responses by targeting NLRP3 in human dental pulp fibroblasts. Int Endod J. 2020. PMID: 32966618. doi:10.1111/iej.13413
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。